1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3 Purity > 98,0% (HPLC) Brexpiprazole Intermediate Factory
Ruifu Kimia Supply Brexpiprazole panengah
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-hiji CAS 913613-82-8
4-Chlorobenzo[b]tiofen CAS 66490-33-3
Ngaran Kimia | 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride |
sinonim | Brexpiprazole panengah 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride |
Nomer CAS | 913614-18-3 |
Nomer CAT | RF-PI1034 |
Status Saham | Dina Stock, Kapasitas Produksi 100MT / Taun |
Formula Molekul | C12H15ClN2S |
Beurat Molekul | 254.7789 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bodas ka Pareum-Bodas Bubuk |
Idéntifikasi | Waktu ingetan sampel saluyu jeung standar rujukan |
Kamurnian / Métode Analisis | > 99,0% (HPLC) |
Leungitna dina Drying | <0,50% |
Cai (KF) | <0,50% |
Résidu on Ignition | <0,20% |
Zat Patali | (HPLC) |
Sakur Najis Pribadi | <0,50% |
Total Kotoran | <1,00% |
Spéktrum Infrabeureum | Conforms kana Struktur |
Proton NMR Spéktrum | Conforms kana Struktur |
Standar tés | Standar Perusahaan |
Pamakéan | Panengah Brexpiprazole (CAS: 913611-97-9) |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) mangrupa perantara Brexpiprazole (CAS: 913611-97-9).Brexpiprazole mangrupakeun jenis antipsychotic atypical.Ieu mangrupikeun agonis parsial reséptor dopamin D2.Salaku modulator kagiatan serotonin-dopamin novel, éta tiasa dianggo pikeun pengobatan schizophrenia, sareng pikeun pengobatan adjunctive pikeun depresi.Éta ogé tiasa masihan efficacy sareng tolerability tina pangobatan adjunctive anu ngadegkeun pikeun karusuhan depressive mayor (MDD).Ubar kasebut nunjukkeun profil farmakologis anu unik, bertindak salaku agonis parsial serotonin 5-HT1A sareng reséptor dopamin D2 sareng antagonis pinuh ku 5-HT2A sareng reséptor noradrenalin α1B / 2C, kalayan pangirut subnanomolar anu sami.Ubar, anu dikembangkeun ku Otsuka sareng Lundbeck, disatujuan dina 2015 ku FDA pikeun pengobatan schizophrenia sareng salaku pangobatan tambahan pikeun déprési.